Physitrack Limited (SE:PTRK)

:PTRK

PTRK

Physitrack Limited

RESEARCH TOOLSreports

Want to see SE:PTRK full AI Analyst Report?

Physitrack Limited (PTRK) Price & Analysis

0 Followers

PTRK Stock Chart & Stats

kr13.15

kr0.20(1.54%)

At close: Mar 06 4:00 PM EST

kr13.15

kr0.20(1.54%)

Day’s Range― - ―

52-Week Rangekr7.56 - kr21.70

Previous CloseN/A

Volume8.48K

Average Volume (3M)49.62K

Market Cap

kr134.96M

Enterprise Valuekr14.97M

Total Cash (Recent Filing)kr435.91K

Total Debt (Recent Filing)kr3.98M

Price to Earnings (P/E)―

Beta0.66

Next Earnings

Jul 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.52

Shares Outstanding16,260,765

10 Day Avg. Volume41,844

30 Day Avg. Volume49,617

Financial Highlights & Ratios

PEG Ratio-0.58

Price to Book (P/B)1.97

Price to Sales (P/S)1.42

P/FCF Ratio5.09

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)kr13.80M

Bulls Say, Bears Say

Bulls Say

Cash Generation & Free Cash Flow GrowthSustained positive operating and free cash flow with double-digit FCF growth provides durable internal funding for product development, customer success, and working-capital needs. Over 2–6 months this reduces reliance on external financing and supports operational continuity despite earnings volatility.

Manageable Leverage And Positive Equity CushionA modest debt-to-equity ratio and positive equity base give the company financial flexibility to fund growth initiatives or absorb losses without immediate refinancing stress. This balance-sheet stability supports strategic execution and preserves optionality over the medium term.

Recurring Subscription Business Model And Enterprise ContractsA subscription and enterprise-sale model creates recurring revenue, higher lifetime customer value, and scalability across clinics and provider networks. Structural stickiness in healthcare workflows supports predictable revenue and retention, a durable advantage for 2–6 months and beyond.

Bears Say

Deeply Negative Net Margin And Volatile ProfitabilityA large net loss erodes shareholder value and constrains reinvestment capacity. The disconnect between strong EBITDA and deep net loss implies interest, tax, depreciation, or one-off items are materially depressing net results, making earnings recovery and consistent profitability uncertain.

Declining Revenue TrendsSignificant negative revenue growth reduces operating leverage and undermines the predictable recurring revenue profile of a subscription business. Continued top-line contraction would limit margin recovery, impede scale benefits, and pressure cash generation over a 2–6 month horizon.

Earnings Quality And Negative Returns On EquityPositive cash flow alongside a large net loss and very negative ROE signals earnings quality issues (timing, non-cash items, or structural losses). If cash strength is temporary, shareholder returns and reinvestment capacity may remain impaired, threatening medium-term financial health.

PTRK FAQ

What was Physitrack Limited’s price range in the past 12 months?

Physitrack Limited lowest stock price was kr7.56 and its highest was kr21.70 in the past 12 months.

What is Physitrack Limited’s market cap?

Physitrack Limited’s market cap is kr134.96M.

When is Physitrack Limited’s upcoming earnings report date?

Physitrack Limited’s upcoming earnings report date is Jul 21, 2026 which is in 43 days.

How were Physitrack Limited’s earnings last quarter?

Physitrack Limited released its earnings results on Apr 23, 2026. The company reported kr0.109 earnings per share for the quarter, beating the consensus estimate of N/A by kr0.109.

Is Physitrack Limited overvalued?

According to Wall Street analysts Physitrack Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Physitrack Limited pay dividends?

Physitrack Limited does not currently pay dividends.

What is Physitrack Limited’s EPS estimate?

Physitrack Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Physitrack Limited have?

Physitrack Limited has 16,260,765 shares outstanding.

What happened to Physitrack Limited’s price movement after its last earnings report?

Physitrack Limited reported an EPS of kr0.109 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.219%.

Which hedge fund is a major shareholder of Physitrack Limited?

Currently, no hedge funds are holding shares in SE:PTRK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Physitrack Limited

Physitrack PLC operates globally as a digital healthcare innovator. The company delivers a proprietary cloud-based Software-as-a-Service (SaaS) platform, utilized by a diverse range of healthcare providers, from individual practitioners to large organizations, to completely digitalize the patient journey—from their initial contact through ongoing interactions and tracking of progress. Additionally, Physitrack offers virtual care solutions that address three key areas for patients and insurance plan members: preventive and wellness support, care for acute and chronic conditions, and surgical recovery. These virtual care services are supplied to healthcare enterprises such as private and public hospitals, clinics, and other health businesses. Founded in 2012, the company was formerly known as Physitrack Limited before rebranding to Physitrack PLC in May 2021 and is based in London, United Kingdom.